Atlas Trials

Relapsing-remitting Multiple Sclerosis

251 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsing-remitting Multiple Sclerosis

RecordFirmDate
A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED) (NCT00239655)Merck Sharp & Dohme LLC2004-08-01
Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS (NCT00202995)Teva Branded Pharmaceutical Products R&D, Inc.2004-07-01
Study To Evaluate The Immunogenicity And Safety Of r-hIFN Beta-1a (Rebif®) Using Clone 484-39 In Multiple Sclerosis (NCT00367484)Merck KGaA, Darmstadt, Germany2004-05-01
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis (NCT00078338)EMD Serono2004-02-16
Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS (NCT00232193)Providence Multiple Sclerosis Center2003-12-01
Atorvastatin in Relapsing-Remitting Multiple Sclerosis (NCT00616187)Charite University, Berlin, Germany2003-10-01
Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta (NCT00493116)Biogen2003-10-01
A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis. (NCT00203073)Teva Branded Pharmaceutical Products R&D, Inc.2003-06-01
Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients (NCT00220493)Sheba Medical Center2003-06-01
Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies (NCT00492466)Biogen2003-03-01
Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS (NCT00168766)Biogen2003-01-01
Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (NCT00534261)Biogen1999-11-01
Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis (NCT00219908)Rennes University Hospital1999-07-01
Vitamin D Pilot Study in Patients With Multiple Sclerosis (NCT01257958)University of Wisconsin, Madison1998-02-01
Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and Effectiveness (NCT00203021)Teva Branded Pharmaceutical Products R&D, Inc.1994-03-26
Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis (NCT01714089)Revalesio Corporation
A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303 (NCT02193217)Tanabe Pharma Corporation
← Previous

Track Relapsing-remitting Multiple Sclerosis automatically

Every clearance here is in the API, with alerts when new ones post.